Literature DB >> 18608852

Right-sided lateralisation of ovarian cancer and right bias asymmetry for involved pelvic lymph nodes by ovarian cancer cells.

Senol Dane1, Bunyamin Borekci, Sedat Kadanali.   

Abstract

The aim of the present study was to investigate if there is a possible lateralisation for ovarian cancers, to re-examine left-right asymmetry in pelvic lymph nodes distribution in patients with ovarian cancer, and to investigate if pelvic lymph node involvement by metastatic invasion of ovarian cancer cells is ipsilateral or contralateral. There was right-sided lateralisation for ovarian cancer. The numbers of external iliac and hypogastric+obturator lymph nodes were higher on the right side in patients with ovarian cancer on the right side; but they were about equal for right and left sides in patients with ovarian cancer in their left side. The numbers of external iliac and hypogastric+obturator lymph nodes involved by metastatic cancer cells were higher on the right side in patients with ovarian cancer on the both right and left sides. This case may result from the stronger cell-mediated immune activity in the left sides of humans.

Entities:  

Mesh:

Year:  2008        PMID: 18608852     DOI: 10.1080/13576500801957636

Source DB:  PubMed          Journal:  Laterality        ISSN: 1357-650X


  3 in total

Review 1.  From cytoskeletal dynamics to organ asymmetry: a nonlinear, regulative pathway underlies left-right patterning.

Authors:  Gary McDowell; Suvithan Rajadurai; Michael Levin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-12-19       Impact factor: 6.237

2.  Left-right asymmetry in neck lymph nodes distribution in patients with bilateral laryngeal cancer.

Authors:  Ozgur Yoruk; Ramazan Yuksel; Yasemin Yuksel; Senol Dane
Journal:  Surg Radiol Anat       Date:  2013-07-30       Impact factor: 1.246

3.  An Evaluation of Right-Sided Symptom Onset as a Predictor of Poor Parkinson's Disease Prognosis.

Authors:  Asuman Orhan Varoğlu; Adem Aydin
Journal:  Cureus       Date:  2021-02-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.